Hao Chen
Shanghai 6th Peoples' Hospital · Fudan University · Mackay Memorial Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hao Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06958406 · Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain InjuryShanghai 6th People's Hospital · recruiting · Traumatic Brain Injury, Cerebrocardiac Syndrome · study director
- N/ANCT06241482 · Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical CareShanghai 6th People's Hospital · recruiting · Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease · study director
- Ph3NCT05840341 · Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic CancerFudan University · completed · Pancreatic Neoplasms · study director
- N/ANCT05549986 · Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS StudyMackay Memorial Hospital · completed · Trauma, Shock, Traumatic, Morality · principal investigator
- N/ANCT05229133 · Efficacy and Safety of CLEAR in Myopia and Astigmatism in Chinese PopulationZiemer Ophthalmic Systems AG · unknown · Myopic Astigmatism · principal investigator
- N/ANCT04525209 · Integrative Proteomic Characterization of Pancreatic Ductal AdenocarcinomaRuijin Hospital · unknown · Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics · principal investigator
- N/ANCT04524637 · The Utility of Thromboelastography in Traumatic Brain InjuryShanghai 6th People's Hospital · recruiting · Traumatic Brain Injury, Coagulation Disorder · study director
- Ph3NCT02510066 · Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer PainShanghai Cancer Hospital, China · unknown · Pancreatic Cancer, Pain · study chair
- N/ANCT02486237 · Complications in Central American Diabetic Patients: Historic CohortClínica Los Yoses · completed · Diabetes Mellitus, Type 2 · principal investigator
- Ph2NCT01715532 · Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPaseFudan University · unknown · Carcinoma, Hepatocellular · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 116 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in pancreatic cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:29 UTC. The ranking covers the 200 most relevant of 21 PubMed records, and a shared surname and initials can bring in a namesake. All 21 on PubMed
- 458 citationsRCR 44.1
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.J Clin Oncol · 201599 citationsRCR 3.2
- A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.Oncologist · 201174 citationsRCR 1.9
- Electroacupuncture treatment for pancreatic cancer pain: a randomized controlled trial.Pancreatology · 201349 citationsRCR 1.9
- Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial.Surg Endosc · 201743 citationsRCR 2.1
- 42 citationsRCR 1.6
- Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.Clin Cancer Res · 202435 citationsRCR 4.2
- 19 citationsRCR 0.4
- LINC01121 Inhibits Cell Apoptosis While Facilitating Proliferation, Migration, and Invasion Though Negative Regulation of the Camp/PKA Signaling Pathway via GLP1R.Cell Physiol Biochem · 201813 citationsRCR 0.5
- 12 citationsRCR 1.1